BCL2L2 and osteosarcoma: These indicate that miR-133b play a role as a tumor suppressor gene in osteosarcoma through inhibiting PI3K/Akt signaling and down-regulating several anti-apoptotic molecules and oncogenes such as BCL2L2, MCL-1, IGF1R, MET, and FAK.